Market Research Report Global Next Generation Sequencing (NGS) Industry V | Page 3

Many players in this market are trying to expand their product portfolio to top the global market. Few companies have adopted product innovation and new product launches as their key business strategies, to ensure their dominance in the market.
Purchase a copy of Global Next Generation Sequencing( NGS) Market visit @ http:// www. orbisresearch. com / contact / purchase / 219849 For more information contact sales @ orbisresearch. com.
The major players operating in the NGS market are- Illumina Inc.( U. S.) Thermo Fisher Scientific( U. S.) Hoffmann-La Roche Ltd( Switzerland) Pacific Biosciences( U. S.) Agilent Technologies( U. S.) BGI( Beijing Genomics Institute)( China) Qiagen( The Netherlands) Biomatters Ltd( New Zealand) Genomatix Software GmbH( Germany)
Key Deliverables in the Study Market analysis for the global next generation sequencing market, with region specific assessments and competition analysis. Market definition along with the identification of key drivers, restraints opportunities and challenges. Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence the market on a global and regional scale. Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information. Identification and analysis of the macro and micro factors that affect the global next generation sequencing market. Insights of the market in the regions that have the highest potential for growth and also to identify the markets that are still untapped.
Browse Complete Report @ http:// www. orbisresearch. com / reports / index / global-next-generationsequencing-ngs-market-growth-trends-and-forecasts-2016-2021.
Some points from TOC:
1. Introduction 1.1 Study Deliverables 1.2 Market Definition 1.3 Sizing Units 1.4 Base Currency www. orbisresearch. com; + 1( 214) 884-6817; + 9120-64101019